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Nursing home residents are at high risk for invasive 
group A streptococcal (GAS) disease, and clusters of cases 
in nursing homes are common.To characterize the epidemi-
ologic features of invasive GAS disease in nursing homes, 
we conducted active, statewide, population- and laboratory-
based surveillance in Minnesota from April 1995 through 
2006. Of 1,858 invasive GAS disease cases, 134 (7%) oc-
curred in nursing home residents; 34 of these cases were 
identiﬁ  ed as part of 13 clusters. Recognizing cases of GAS 
disease in nursing homes posed challenges. Measures to 
ensure identiﬁ  cation of case-patients as residents of spe-
ciﬁ  c nursing homes need to be included in standard guide-
lines for the prevention and control of invasive GAS disease 
in this setting.
S
treptococcus pyogenes, or group A Streptococcus (GAS), 
is most commonly associated with noninvasive condi-
tions such as pharyngitis and impetigo but can also cause 
severe invasive GAS infections such as necrotizing fasciitis 
and streptococcal toxic shock syndrome (STSS) (1–3). Risk 
factors for invasive GAS disease include advanced age, 
diabetes mellitus, cardiac disease, chronic obstructive pul-
monary disease, cancer, immunocompromising conditions, 
and varicella (4,5). Most nursing home residents have at 
least one of these risk factors, which makes this popula-
tion especially vulnerable to invasive GAS disease. An es-
timated 8,950 to 11,500 (3.5/100,000 population) invasive 
cases and 1,050 to 1,850 deaths occur in the United States 
annually (6). The incidence among persons >65 years of 
age of 9.4/100,000 population is almost 3 times that of the 
general population (6).
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Most of the literature about GAS disease in nursing 
homes has focused on acute outbreaks with little attention 
paid to sporadic disease in this setting (7–19). Factors con-
tributing to these outbreaks include GAS-infected caregiv-
ers, inadequate infection control measures, resident-to-res-
ident spread, and the presence of a chronically infected or 
persistently colonized resident (7–17). On the basis of our 
experience with GAS surveillance in Minnesota, we sus-
pect that a lack of recognition of GAS disease occurrence 
within nursing homes may also be a contributing factor.
We describe the occurrence of invasive GAS disease 
among residents of nursing homes in Minnesota over 11 
years, the challenges we encountered with surveillance, 
and our efforts to prevent and control the spread of disease 
in this setting. Our ﬁ  ndings will be useful in the develop-
ment of guidelines for the prevention and control of GAS 
disease in nursing homes.
Methods
Surveillance
We began active, statewide, population- and labora-
tory-based surveillance for invasive GAS disease in April 
1995 through Active Bacterial Core surveillance (ABCs), 
part of the Emerging Infections Program of the Centers for 
Disease Control and Prevention (CDC) (20). The popula-
tion of Minnesota was 4.9 million in 2000. Invasive GAS 
disease is deﬁ  ned as GAS isolated from a normally sterile 
site such as blood or cerebrospinal ﬂ  uid or from a wound 
when accompanied by STSS or necrotizing fasciitis (20). 
To ensure complete case capture, laboratories either submit 
computerized lists of all GAS-positive cultures from nor-
mally sterile sites at least monthly or are contacted twice 
monthly by Minnesota Department of Health (MDH) staff, 
and audits are completed routinely. Hospital infection con-
trol practitioners then complete standard report forms for 
cases of invasive disease, and all GAS isolates are sent to 
the MDH Public Health Laboratory. All GAS isolates un-
dergo pulsed-ﬁ  eld gel electrophoresis (PFGE) with Sma1 
by methods described elsewhere, with the exception that an 
Enterococcus isolate was used as the standard (21). PFGE 
patterns are evaluated both visually and with BioNumer-
ics software (Applied Maths, Kortrijk, Belgium) by using 
the dice coefﬁ  cient. For patterns to be considered indistin-
guishable, they must visually appear identical and the DNA 
patterns must differ by <1.5% with respect to molecular 
weight. Isolates are also sent to CDC for emm typing (22).
Beginning in 1995, information about a case-patient’s 
residence was collected on the case report form, including 
street address, city, state, and ZIP code. In 1998, a ques-
tion was added about whether the case-patient had been a 
resident of a nursing home, long-term care facility (LTCF), 
or other chronic care facility for at least 30 days before 
the date the culture was collected. Persons living in group 
homes, prisons, rehabilitation hospitals, or who were going 
to facilities for daily outpatient therapy were not included. 
Beginning in 2002, the name of the facility was collected. 
Addresses for case-patients >55 years of age were also 
checked by a reverse address directory to see whether they 
corresponded with that of an LTCF. Information about size, 
location, and classiﬁ  cation of LTCFs was collected from a 
directory of Minnesota licensed, certiﬁ  ed, and registered 
healthcare facilities.
For the purposes of this study, only case-patients who 
could be conﬁ  rmed as residents of nursing homes were in-
cluded because accurate denominator data were only avail-
able for this group. In Minnesota, a nursing home is deﬁ  ned 
as a facility that provides nursing care to >5 persons who 
are not in need of acute care facilities but require nursing 
supervision on an inpatient basis. Denominators for calcu-
lating incidence were derived from the 2000 US Census 
data as reported by the Minnesota State Demographic Cen-
ter, which describe the population living in group quarters 
by age and type of quarters (23).
Cluster Identiﬁ  cation
We deﬁ  ned a nursing home cluster as >2 cases in resi-
dents of a nursing home in which isolates were nearly identi-
cal as determined by PFGE (PFGE patterns within a 3-band 
difference [24]) during a 12-month period. PFGE patterns 
were used for cluster identiﬁ  cation because they were more 
discriminating than emm types (e.g., several PFGE pat-
terns were typically found to correspond to 1 emm type, 
while PFGE patterns were not found to have multiple emm 
types), and PFGE was readily available in our laboratory. 
We chose 12 months because we observed that invasive 
cases with indistinguishable patterns sometimes occurred 
many months apart within a facility. Beginning in 1995, 
case reports were reviewed regularly by address, facility 
name, and PFGE pattern to look for clusters.
EpiInfo version 6.0 (www.cdc.gov/epiinfo/Epi6/EI6-
dnjp.htm) was used for statistical analysis. χ2 test was used 
to determine statistical signiﬁ  cance of differences in pro-
portions for discrete variables, and a t test was used to de-
termine whether the difference in means was signiﬁ  cant for 
continuous variables.
Intervention
Since 1997, whenever a cluster was identiﬁ  ed through 
ABCs, the nursing home was contacted by MDH and en-
couraged to conduct retrospective and enhanced prospective 
surveillance for invasive and noninvasive GAS infections. 
This surveillance included reviewing culture logs to identify 
noninvasive GAS infections and residents with chronic or 
recurrent infections and reviewing reported staff illnesses 
to identify a possible source of GAS. Clinical examples of 
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possible GAS infections were provided so the facility could 
consider the possibility of earlier undiagnosed GAS disease 
and recognize new suspect cases. For prospective surveil-
lance, the nursing home was encouraged to obtain cultures 
for any suspected infection and to ask laboratories to save 
GAS isolates for PFGE and emm typing. A follow-up letter 
and packet of information about GAS and infection control 
measures were also sent to the nursing home. We offered 
assistance of further investigation but most often had no fur-
ther contact with the facility. In 2004, after noting that we 
seldom observed another case at a facility after we contacted 
them regarding a cluster, we began to contact a facility any 
time we received a report of a single case.
In Minnesota, MDH staff cannot conduct an investiga-
tion in a nursing home without an invitation from the facil-
ity. Only 2 facilities with clusters requested our assistance. 
These investigations have been described in detail else-
where (25,26), but in both instances cultures were collected 
from residents and staff (all residents and staff at facility G; 
all but 1 resident who refused and 3 staff members in the 
affected unit at facility B). Those with positive GAS cul-
tures were treated with antimicrobial agents (clindamycin 
at facility G and penicillin and rifampin at facility B). For-
mal infection control educational sessions were provided 
for staff on the same day that cultures were collected.
Results
Surveillance
From April 1995 through 2006, 1,858 cases of inva-
sive GAS disease were reported among Minnesota resi-
dents; 642 (35%) were in persons >65 years of age. One 
hundred seventy-ﬁ  ve case-patients were identiﬁ  ed as LTCF 
residents on their case report forms. Twenty-three of these 
case-patients resided in non–nursing home settings such 
as assisted living or group homes, and we were unable to 
determine the type of setting for 18 of those designated as 
LTCF residents. One hundred thirty-four (7%) of our case-
patients were known to be nursing home residents. The 
number and percentage of all cases associated with nursing 
homes ﬂ  uctuated over time; from 6 to 21 cases were identi-
ﬁ  ed among nursing home residents annually, representing 
3%–12% of all case-patients each year (Figure 1). Seasonal 
variation of invasive GAS infections was noted among both 
the general population and nursing home residents (Figure 
2), with peak incidence in the winter and spring and little 
disease noted in late summer and early fall.
The age of nursing home case-patients ranged from 36 
to 100 years of age (median 84 years); 58% were women, 
87% had positive blood cultures, 36% had bacteremia with-
out another focus of infection, 32% had cellulitis, and 12% 
had pneumonia. The case-fatality ratio of all case-patients 
with invasive GAS was 12%. Among case-patients >65 years 
of age, the case-fatality rate of nursing home resident case-
patients (n = 121) was 35% compared with 18% of case-
patients who were not nursing home residents (n = 521).
In 2000, 37,542 Minnesota residents >65 years of age 
lived in nursing homes, and 556,724 lived in their own 
homes or other group quarters. During 2000, the incidence 
of invasive GAS infections among Minnesota nursing 
home residents >65 years was 18.6 cases/100,000 popu-
lation compared with 6.8 cases/100,000 among those >65 
years who did not reside in nursing homes. Estimated an-
nual incidence for nursing home residents >65 years varied 
from 13.3 cases/100,000 in 1997 to 50.6 cases/100,000 in 
2003, while the estimated incidence for non–nursing home 
residents >65 years was 8.6 and 9.3 cases/100,000 during 
the same years.
Emm type was available for 117 (87%) of the nursing 
home case-patient isolates. Of 21 different emm types iden-
tiﬁ  ed, 4 (emm 1 [21%], emm 89 [15%], emm 28 [13%], and 
emm 03 [11%]) accounted for 60% of the isolates. Among 
1,416 (82%) non–nursing home case-patients, 5 emm types 
accounted for 62% of the isolates (emm 1 [24%], emm 28 
[13%], emm 03 [11%], emm 12 [10%], and emm 89 [4%]). 
Although total numbers of cases varied considerably from 
one year to the next, the proportion of disease caused by the 
most common emm types ﬂ  uctuated little.
Cluster Identiﬁ  cation
Of the 444 licensed nursing homes in Minnesota, 91 
(20%) were known to have at least 1 case of invasive GAS 
disease during the study period. Sixty-seven (74%) of these 
facilities had a single case; 13 facilities had 2 cases; and 11 
facilities had >3 cases. Of 24 facilities that had >2 cases, 13 
(54%) met the deﬁ  nition of a cluster as previously deﬁ  ned 
(Table). We found that PFGE patterns for isolates from 
the same facilities were either indistinguishable from each 
other or distinctly different (>3 bands different).
Four nursing homes that had clusters also had addi-
tional cases that did not ﬁ  t the deﬁ  nition for inclusion in 
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Figure 1. Annual number of cases of invasive group A streptococcal 
infections and percentage of cases occurring among nursing home 
residents, April 1995–2006. LTCF, long-term care facility.Streptococcal Disease in Nursing Homes
the cluster, either because a case isolate had a distinctly 
different PFGE pattern, a case did not occur within 1 year 
of the other cases, or both. One of these facilities had 4 such 
cases. In addition, 11 other nursing homes each had 2–3 
cases that did not ﬁ  t the deﬁ  nition of a cluster.
All but 2 clusters were caused by the most common 
emm types. Emm 1 was the most common cause of invasive 
disease (causing 24% of all cases) and also the cause of 5 
(38%) clusters.
Eighteen of 21 pairs (86%) of consecutive cases oc-
curring within 12 months of each other in the same facility 
had matching PFGE patterns, while 13 (93%) of 14 pairs 
of consecutive cases occurring within 3 months had match-
ing patterns. The occurrence of a third case in a nursing 
home was not dependent on the ﬁ  rst 2 case isolates having 
the same PFGE patterns; 6 (46%) of 13 facilities in which 
the ﬁ  rst 2 case isolates had different PFGE patterns and 5 
(45%) of 11 facilities in which the ﬁ  rst 2 case isolates had 
matching PFGE patterns subsequently had more cases.
No signiﬁ  cant difference was found for age, sex, or 
type of infection between cluster and sporadic cases. Forty-
one percent of case-patients with cluster-associated cases 
died, compared with 32% of patients with sporadic cases, 
but this difference was not signiﬁ  cant (p = 0.33).
Intervention
In 32 (86%) of 37 encounters with nursing staff, the 
person contacted was not aware of a diagnosis of invasive 
GAS disease among their residents before our call. In ad-
dition, even when our contacts (usually either directors of 
nursing or nurses designated to oversee infection control 
for the facility) did know of the diagnosis, they generally 
had little knowledge about GAS disease. Before 2004, we 
noted that 9 of 12 nursing homes did not identify additional 
cases of invasive disease after our call. In 2004, we began 
notifying nursing homes after we identiﬁ  ed single cases in 
their facilities. Since then, we are aware of only 1 facility 
with a cluster, and that facility had 2 cases 4 days apart.
We collected throat and skin lesion cultures from staff 
and residents for a unit with a cluster of invasive GAS dis-
ease at facility B and from staff and residents of the entire 
nursing home at facility G. At facility B, 2 (2.7%) of 75 
throat cultures from staff and 2 (5.9%) of 34 throat cultures 
from residents were positive for GAS; 5 (6.2%) of 81 throat 
cultures from staff and 2 (4.5%) of 44 throat cultures of 
residents were positive for GAS at facility G. All of those 
with positive throat cultures were asymptomatic at the time 
of culture. All except 1 isolate from a staff person at facil-
ity G who did not provide direct patient care had PFGE 
patterns indistinguishable from those associated with the 
invasive cases at the facility. Those with positive cultures 
were each treated with a course of antimicrobial drugs, and 
no additional cases were detected at either facility.
Discussion
Minnesota has had a unique opportunity to conduct 
active, population-based surveillance for invasive GAS 
disease for >11 consecutive years with nearly complete 
case reporting plus further molecular characterization of 
associated GAS isolates. Findings from this statewide sur-
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 14, No. 5, May 2008  775 
Figure 2. Number of cases of invasive group A streptococcal 
infections and percentage of cases occurring among nursing home 
residents by month of culture, Minnesota, 1995–2006.
Table. Clusters of invasive group A streptococcal disease in nursing homes, Minnesota, April 1995–2006 
Facility Year(s) 
Month of onset for 
first case  No. cases 
Interval between first 
and second case 
Interval between first 
and last case  emm type
A 1995 Apr 4 1 mo  7 mo  01
B 1996–1997 Jan 5 10 mo  16 mo  89
C 1998 Feb 2 5 mo  5 mo  01
D 2000 May  2 2 mo  2 mo  82
E 2001 Apr 2 3 wk  3 wk  01
F 2002 Feb 2 9 mo  9 mo  28
G 2002 Mar 3 3 wk  3 mo  01
H 2002–2003 Dec 3 3 mo  3.5 mo  03
I 2003 Jan 2 2 mo  2 mo  89
J 2003 May  2 1 wk  1 wk  28
K 2003 Feb 3 2 wk  9 mo  01
L 2003–2004 Dec 2 1 mo  1 mo  12
M 2004 Feb 2 4 d  4 d  05RESEARCH
veillance, our review of the strengths and weaknesses of 
GAS surveillance speciﬁ  c for nursing homes, and further 
evaluation of factors associated with clusters of GAS in this 
setting provide information to aid in the development of ef-
fective national guidelines for the prevention and control of 
GAS infections in this vulnerable population.
Although <2% of Minnesota’s population resides in 
nursing homes, at least 7% of invasive GAS cases occurred 
among this population. As noted in other studies (27), we 
also found that the case-fatality rate was higher for nursing 
home residents than for the rest of the population. Much 
of this increase in illness is likely due to the frequency of 
risk factors for invasive GAS disease among this popula-
tion (e.g., advanced age and underlying diseases such as 
diabetes and chronic obstructive pulmonary disease); how-
ever, the increase may also be due to difﬁ  culties of limiting 
the introduction and transmission of GAS in this or any 
institutional setting or in a closed population.
The true incidence of GAS disease in nursing homes 
and the occurrence of clusters are likely higher than de-
tected by our surveillance system. Collection of specimens 
from febrile nursing home residents is limited when infec-
tions in nursing home residents are treated empirically. In 
addition, our early surveillance methods likely misclas-
siﬁ  ed the residence of GAS case-patients. We found that 
the street addresses for patients that were obtained from 
hospital admission records were often not the addresses of 
the nursing homes where case-patients resided but were in-
stead the home address of a spouse or other family member. 
The percentage of case-patients with invasive GAS disease 
identiﬁ  ed as living in nursing homes rose markedly in 1998 
when a speciﬁ  c question about LTCF residence was added 
to the ABCs case report form. In 2002, we began collect-
ing the name of the facility where potential case-patients 
resided, enabling nursing home residence to be conﬁ  rmed. 
Because of these improvements in methods over time, we 
cannot appropriately compare our early nursing home dis-
ease rates to those calculated from more recent data to draw 
conclusions about changes in trends.
Prevention and effective control of GAS infections in 
nursing home residents can be improved with changes in 
surveillance. Knowledge of the initial case in a facility may 
help prevent a second case through review and improve-
ment of infection control in the facility, the identiﬁ  cation 
of and treatment for a colonized or infected staff member, 
or segregation of infected patients. We found that nurs-
ing homes were frequently unaware that their hospitalized 
residents had invasive GAS disease until notiﬁ  ed by pub-
lic health ofﬁ  cials. All GAS infections identiﬁ  ed by refer-
ring hospitals must be reported back in a timely manner to 
the nursing homes from which a patient was transferred. 
Surveillance for noninvasive GAS infections may also be 
needed. Because these infections are not reportable, nursing 
home staff and public health personnel may not be aware 
of the ﬁ  rst introduction of GAS into a facility or ongoing 
transmission when the onsets of invasive GAS cases are 
separated by long periods.
Given the current limitations of public health surveil-
lance, nursing home staff, especially those responsible for 
infection control, must be educated speciﬁ  cally about GAS 
disease and its transmission. Hospital infection control 
practitioners may be in the best position to ﬁ  nd cases and to 
inform nursing homes when they review culture results for 
hospital surveillance.
We found further characterization of GAS isolates help-
ful when confronted with multiple cases of GAS disease in 
a facility. Even if laboratory resources are scarce, nursing 
home isolates of GAS should be saved for future testing 
if additional cases occur. Both emm typing and PFGE are 
useful tools when attempting to determine whether >2 cases 
are related. A high percentage of temporally related cases 
had isolates with indistinguishable PFGE patterns, which 
suggests that continued transmission of a single strain is 
occurring in a facility, although reintroduction of a simi-
lar strain from the community cannot be excluded. In half 
of the situations in which a nursing home had 2 invasive 
cases, additional cases occurred regardless of whether the 
GAS isolates from the ﬁ  rst 2 case-patients had matching 
PFGE patterns, which suggests a failure of infection control 
in these facilities. Although knowledge of GAS strain relat-
edness identiﬁ  ed through PFGE or emm typing can help 
identify the source of the GAS infection, circulating within 
a facility or introduced from the community, we conclude 
that a thorough investigation is warranted when >1 case 
has occurred in a facility within a few months. Emm typing 
is not readily available in most public health laboratories; 
however, the results of emm typing of GAS isolates from 
ongoing ABCs is important for researchers currently devel-
oping multivalent GAS vaccines. The types most common 
among our nursing home case-patients are included in a 26-
valent vaccine that has completed a phase II trial (28).
Although most invasive GAS disease cases occurring 
in nursing homes are sporadic, our experience suggests that 
the time of ﬁ  rst awareness of any GAS disease in a nurs-
ing home is also the time to assess the extent of spread and 
institute infection control measures. Clinical syndromes of 
GAS should be reviewed with staff, and the importance of 
excluding staff and visitors with illness should be empha-
sized. Hand hygiene among staff, visitors, and residents 
needs to be emphasized. We also recommend that surveil-
lance for GAS disease, including noninvasive disease, be 
implemented and that cultures be obtained from patients 
with potential cases. If ongoing transmission and disease 
continue, additional measures, such as performing screen-
ing cultures for GAS, can be helpful.
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